Preventing overweight and obesity in women through mindful eating, dance and yoga exercises

Effects of mindful eating and YogaDance among overweight and obese women – an exploratory randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN87234794

Enrollment

Registered

2023-02-27

Start date

2021-11-01

Completion date

Unknown

Last updated

2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of overweight and obesity in women Nutritional, Metabolic, Endocrine

Interventions

Participants were allocated by block randomization to one of three intervention groups (mindful eating alone, YogaDance alone, or mindful eating and YogaDance combined) or the control group in a 1:1:

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women between 18 and 65 years of age 2. Body mass index (BMI) between 25-35 kg/m² and/or a waist circumference of =80 cm 3. Healthy 4. Have an inactive lifestyle, defined as <2.5 hours of light physical activity per week or <1 hour of moderate to hard physical activity per week

Exclusion criteria

Exclusion criteria: 1. Pregnant, breastfeeding or plan to become pregnant within the study period 2. Self-reported severe disease (including cancer, cardiovascular disease [CVD], type 1 or 2 diabetes, osteoporosis) 3. Self-reported eating disorder (e.g., anorexia, bulimia, orthorexia, binge eating disorder) 4. Following a very restrictive diet (i.e. excluding several food items) 5. Participation in other studies

Design outcomes

Primary

Measure	Time frame
Fat mass is measured using a dual-energy x-ray absorptiometry (DXA) scanner (Lunar iDXA with CoreScan module, GE Healthcare, Denmark) at baseline and again at end of the study after 8 weeks	—

Secondary

Measure	Time frame
Measured at baseline and after the intervention was completed (at 8 weeks): 1. Body weight measured using a calibrated digital scale (Tanita WB-110MA) 2. BMI defined as body weight divided by height squared 3. Waist circumference measured using a non-elastic band 4. Fat percent measured using a DXA scanner 5. Fat-free mass measured using a DXA scanner 6. Visceral fat measured using a DXA scanner 7. Bone mineral density measured using a DXA scanner 8. Blood pressure measured using a validated automatic blood pressure monitor (UA-787 Plus) 9. Quality of life measured using the WHO-QOL-100 questionnaire 10. Eating behavior measured using a Danish version of the IES-2 questionnaire 11. Energy intake measured using 3-day dietary records 12. Physical activity measured using the International Physical Activity Questionnaires (IPAQ)	—

Measure

Time frame

Measured at baseline and after the intervention was completed (at 8 weeks): 1. Body weight measured using a calibrated digital scale (Tanita WB-110MA) 2. BMI defined as body weight divided by height squared 3. Waist circumference measured using a non-elastic band 4. Fat percent measured using a DXA scanner 5. Fat-free mass measured using a DXA scanner 6. Visceral fat measured using a DXA scanner 7. Bone mineral density measured using a DXA scanner 8. Blood pressure measured using a validated automatic blood pressure monitor (UA-787 Plus) 9. Quality of life measured using the WHO-QOL-100 questionnaire 10. Eating behavior measured using a Danish version of the IES-2 questionnaire 11. Energy intake measured using 3-day dietary records 12. Physical activity measured using the International Physical Activity Questionnaires (IPAQ)

—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026